TherapeuticsMD, INC. (NYSE MKT:TXMD), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women, today announced that the Company will present at the Jefferies 2013 Global Healthcare Conference to be held June 3-6, 2013 at the Grand Hyatt New York.
Robert Finizio, Chief Executive Officer, will present on Wednesday, June 5, 2013 at 1:30 p.m. Eastern Daylight Time.
The presentation will also be available via a live audio webcast at the following link: http://wsw.com/webcast/jeff77/txmd/
Following the presentation, a replay will be available through TherapeuticsMD’s website at www.therapeuticsmd.com under the "Investor Relations" section and will remain available for 30 days after the actual presentation date.
About TherapeuticsMD, INC.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD® and BocaGreenMD™ brands. We are currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. We are also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com, and www.bocagreenmd.com.
vitaMedMD® is a registered trademark and TherapeuticsMD™ and BocaGreenMD™ are trademarks of TherapeuticsMD, Inc.
<div class="copyright"> Copyright Business Wire 2013 </div>